Results 31 to 40 of about 26,715,422 (73)

Targeted Therapy Modulates the Secretome of Cancer-Associated Fibroblasts to Induce Resistance in HER2-Positive Breast Cancer. [PDF]

Int J Mol Sci, 2021
Luque M, Sanz-Álvarez M, Santamaría A, Zazo S, Cristóbal I, de la Fuente L, Mínguez P, Eroles P, Rovira A, Albanell J, Madoz-Gúrpide J, Rojo F.   +11 more
europepmc   +1 more source

Targeting body composition in an older population: do changes in movement behaviours matter? Longitudinal analyses in the PREDIMED-Plus trial. [PDF]

BMC Med, 2021
Galmes-Panades AM, Konieczna J, Varela-Mato V, Abete I, Babio N, Fiol M, Antonio de Paz J, Casas R, Olbeyra R, Ruiz-Canela M, Palau-Galindo A, Castañer O, Martín-García A, Estruch R, Vidal J, Buil-Cosiales P, Wärnberg J, Salas-Salvadó J, Martínez JA, Romaguera D, PREDIMED-Plus investigators.   +20 more
europepmc   +1 more source

Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in Multiple Myeloma [PDF]

Blood Adv
Palacios-Berraquero ML, Rodriguez-Marquez P, Calleja-Cervantes ME, Berastegi N, Zabaleta A, Burgos L, Alignani D, San Martin-Uriz P, Vilas-Zornoza A, Rodriguez-Diaz S, Inoges S, Lopez-Diaz de Cerio A, Huerga S, Tamariz E, Rifón J, Alfonso-Pierola A, Lasarte JJ, Paiva B, Hernaez M, Rodriguez-Otero P, San Miguel J, Ezponda T, Rodriguez-Madoz JR, Prosper F.   +23 more
europepmc   +2 more sources

Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma. [PDF]

Genome Res, 2020
Ordoñez R, Kulis M, Russiñol N, Chapaprieta V, Carrasco-Leon A, García-Torre B, Charalampopoulou S, Clot G, Beekman R, Meydan C, Duran-Ferrer M, Verdaguer-Dot N, Vilarrasa-Blasi R, Soler-Vila P, Garate L, Miranda E, San José-Enériz E, Rodriguez-Madoz JR, Ezponda T, Martínez-Turrilas R, Vilas-Zornoza A, Lara-Astiaso D, Dupéré-Richer D, Martens JHA, El-Omri H, Taha RY, Calasanz MJ, Paiva B, San Miguel J, Flicek P, Gut I, Melnick A, Mitsiades CS, Licht JD, Campo E, Stunnenberg HG, Agirre X, Prosper F, Martin-Subero JI.   +38 more
europepmc   +1 more source

Prevalence of modifiable factors limiting treatment efficacy of poorly controlled asthma patients: EFIMERA observational study. [PDF]

NPJ Prim Care Respir Med, 2020
Ribó P, Molina J, Calle M, Maiz L, Campo C, Rytilä P, Plaza V, Valero A.   +7 more
europepmc   +1 more source

Proceedings of the second annual meeting of GenE-HumDi (COST Action 21113). [PDF]

Front Genome Ed
Ortiz-Bueno M, Ramos-Hernández I, Algeciras-Jiménez L, Kalter N, Rodríguez-Madoz JR, Bonafont J, Nair RR, Feeney O, Torella L, Montoliu L, Patsali P, Mussolino C, Luo Y, Xhetani M, Cavazza A, Hendel A, Benabdellah K, Lederer CW, Molina-Estévez FJ.   +18 more
europepmc   +1 more source

Characterization of the bone marrow architecture of multiple myeloma using spatial transcriptomics. [PDF]

Commun Biol
Muiños-Lopez E, Lopez-Perez AR, Sudupe L, Vilas-Zornoza A, Sarvide S, Ripalda-Cemborain P, Aguirre-Ruiz P, Martin-Uriz PS, Larrayoz M, Alvarez-Gigli L, Abengozar-Muela M, Cenzano I, Cócera M, Ruiz J, Sancho I, Bantan A, Kurowska A, Ye J, Newton PT, Paiva B, Tamariz-Amador LE, Rodriguez-Madoz JR, Lagani V, Tegner J, Saez B, Martinez-Climent JA, Calvo IA, Gomez-Cabrero D, Prosper F.   +28 more
europepmc   +1 more source

Chaperone-mediated autophagy sustains pericyte stemness necessary for brain tissue homeostasis. [PDF]

J Adv Res
Salinas MD, Martínez CM, Roca FJ, García-Bernal D, Martínez-Morga M, Rodríguez-Madoz JR, Prósper F, Zapata AG, Moraleda JM, Martínez S, Valdor R.   +10 more
europepmc   +1 more source

Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas. [PDF]

Cancers (Basel), 2021
Lüttich L, Besso MJ, Heiden S, Koi L, Baumann M, Krause M, Dubrovska A, Linge A, Kurth I, Peitzsch C.   +9 more
europepmc   +1 more source